» Articles » PMID: 14634103

CD19 Function in Early and Late B Cell Development. II. CD19 Facilitates the Pro-B/pre-B Transition

Overview
Journal J Immunol
Date 2003 Nov 25
PMID 14634103
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Proliferative expansion of pro-B cells is an IL-7-dependent process that allows for the rearrangement of H chain genes and the expression of the pre-B cell receptor (pre-BCR). Further B cell differentiation is dependent upon signals elicited through the pre-BCR, which are thought to be responsible for allelic exclusion, induced L chain gene rearrangement, and continued proliferation. CD19 promotes the proliferation and survival of mature B cells, but its role in early B cell development is less well understood. Here we identify and characterize impairments in early B cell development in CD19(-/-) mice. Following sublethal irradiation, we found decreased numbers of autoreconstituted early B cells, which was first evident in the large cycling pre-B cell fraction. Reduced cell progression due to a defect in proliferation was made evident from cell cycle analysis and bromodeoxyuridine labeling of bone marrow cells from CD19(-/-) and wild-type mice. Studies of IL-7-dependent pre-B cell cultures derived from wild-type and CD19(-/-) mouse bone marrow suggested that CD19 has little affect on IL-7 signaling. By contrast, signaling through the pre-BCR was impaired in the absence of CD19, as demonstrated by reduced activation of Bruton's tyrosine kinase and extracellular signal-regulated kinase/mitogen-activated protein kinase. Thus, in addition to promoting mature B cell homeostasis and Ag-induced responses, the early onset of CD19 expression acts to enhance B cell generation.

Citing Articles

Isolation and Analysis of B-cell Progenitors from Bone Marrow by Flow Cytometry.

Zhao H, Sciammas R, Barlow J Bio Protoc. 2023; 13(19):e4835.

PMID: 37817907 PMC: 10560687. DOI: 10.21769/BioProtoc.4835.


Transformed Waldenström Macroglobulinemia Responsive to Tafasitamab Plus Lenalidomide: A Case Report.

Nasir S, Pandya D, Wojkiewicz S, Khandpur B, Downes E, Pathare P Cureus. 2023; 14(12):e32403.

PMID: 36636536 PMC: 9831276. DOI: 10.7759/cureus.32403.


CD19 Chimeric Antigen Receptor-Exosome Targets CD19 Positive B-lineage Acute Lymphocytic Leukemia and Induces Cytotoxicity.

Haque S, Vaiselbuh S Cancers (Basel). 2021; 13(6).

PMID: 33808645 PMC: 8003442. DOI: 10.3390/cancers13061401.


ZhenQi FuZheng formula-mediated improvement of hematopoietic function in cyclophosphamide-treated mice via the upregulation of macrophage colony-stimulating factor concentrations.

Li D, Chu Q, Wang S, Li L, Dou B, He J Clin Transl Med. 2020; 10(8):e256.

PMID: 33377653 PMC: 7744025. DOI: 10.1002/ctm2.256.


Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development.

Burrows N, Bashford-Rogers R, Bhute V, Penalver A, Ferdinand J, Stewart B Nat Immunol. 2020; 21(11):1408-1420.

PMID: 32868930 PMC: 7613233. DOI: 10.1038/s41590-020-0772-8.